The “Personalized Nutrition Market – Global Outlook and Forecast 2023-2028”report has been added to ResearchAndMarkets.com’s offering. The global personalized…
Author: admin
Virtual Fitness Market to be Worth $106.4 Billion by 2030: Grand View Research, Inc.
The global virtual fitness market size is expected to reach USD 106.4 billion by 2030 and is expected to expand…
Pharmaceutical cartridges market size to increase by USD 540.18 million from 2022 to 2027; North America to account for 37% of market growth – Technavio
The Pharmaceutical Cartridges Market by Material, Capacity, and Geography – Forecast and Analysis 2023-2027 report has been published…
Daewoong Pharmaceutical Reaches Sales of KRW 1.16 Trillion in 2022, Fexuclue Leads The Highest Revenue
Daewoong Pharmaceutical (CEO Seng-ho Jeon, Chang-jae Lee) announced its 2022 annual report. On a standalone basis,…
Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth – Technavio
The Cancer Supportive Care Market by Therapeutic Area, Distribution Channel, and Geography – Forecast and Analysis 2023-2027 report…
Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB.1.5 and BA.5 by WestVac Biopharma
Recently, with the support of the National Key R&D Program of China, following the clinical trial approval…
Johnson // Becker, PLLC Files Second Tepezza Hearing Loss Lawsuit
Johnson//Becker, PLLC is a nationwide products liability law firm with extensive experience representing victims of product…
Reckitt Recalls Two Batches of ProSobee 12.9 oz Simply Plant-Based Infant Formula Because of Possible Health Risk
Reckitt, a producer of nutrition products, announced today that, out of an abundance of caution, it…
Disposable Respirator Market Size to Grow USD 2782.7 Million by 2029 at a CAGR of 3.4% | Valuates Reports
The Disposable Respirator Market is Segmented by Type (Valved Disposable Respirator, Unvalved Disposable Respirator), by Application (Paediatric &…
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding and…